VU0448088 (ML253)
Maka nyocha sayensị naanị, ọ bụghị maka ndị ọrịa.
Nkọwa ngwaahịa
Mkpado ngwaahịa
| Nha ngwugwu | Nnweta | Ọnụ ego (USD) |
Aha kemịkalụ:
3-amino-5-chloro-4,6-dimethyl-N- (pyridin-4-ylmethyl)thieno [2,3-b] pyridine-2-carboxamide
Koodu Ọchịchọ:
CC1=NC2=C(C(N)=C(S2)C(NCC3=CC=NC=C3)=O)C(C)=C1Cl
Koodu InChi:
InChi=1S/C16H15ClN4OS/c1-8-11-13(18)14(23-16(11)21-9(2)12(8)17)15(22)20-7-10-3-5- 19-6-4-10/h3-6H,7,18H2,1-2H3,(H,20,22)
Igodo InChi:
XNCQMFVABACABG-UHFFFAOYSA-N
Okwu:
1417616-42-2;CAS:1417616-42-2;CAS:1417616-42-2;VU0448088;ML253;ML 253;ML-253
Solubility:
Nchekwa:
Nkọwa:
VU0448088 (ML253) bụ ezigbo modulator allosteric dị mma nke tricyclic muscarinic acetylcholine receptor subtype 4 (M4) nke nwere ike ịgafe mgbochi ụbụrụ ọbara.
Ebumnuche: tricyclic muscarinic acetylcholine receptor subtype 4 (M4)
![Octahydro-1H-cyclobuta[cd] pentalen-1-otu](http://www.caerulumpharm.com/uploads/微信截图_20230912123242.png)
![(S) -2- (4- (4- (4- (5- (1-amino-1---4-fluorophenyl) ethyl) pyrimidin-2-yl) piperazin-1-yl) pyrrolo [2,1-] f [1,2,4]triazin-6-yl)-1H-pyrazol-1-yl)ethan-1-ol](http://www.caerulumpharm.com/uploads/微信截图_20220802163212-300x280.png)
![1H-Indol-7-amine, 3-[5-fluoro-2-[[2-fluoro-3- (methylsulfonyl) phenyl] amino]-4-pyrimidinyl] -](http://www.caerulumpharm.com/uploads/20240607145458.jpg)
